Advancement of Hemamax Towards BLA Submission for the Mitigation of Hsars Under the FDA Animal Rule
Contract Overview
Contract Amount: $51,041,561 ($51.0M)
Contractor: Neumedicines Inc.
Awarding Agency: Department of Health and Human Services
Start Date: 2011-09-15
End Date: 2018-09-30
Contract Duration: 2,572 days
Daily Burn Rate: $19.8K/day
Official Description: ADVANCEMENT OF HEMAMAX TOWARDS BLA SUBMISSION FOR THE MITIGATION OF HSARS UNDER THE FDA ANIMAL RULE
Place of Performance
Location: California, 91107